NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. Relative Strength Chart Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.23 CNY | +0.08% |
|
-5.71% | -18.47% |
| 06-03 | US FDA Approves Additional Production Site for King-Friend Biochemical Pharma's Melanoma, Hodgkin's Disease Drug | MT |
| 05-28 | Hybio Pharmaceutical Gets Nod to Market Ganirelix Acetate Injection | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. | Other Pharmaceuticals | +0.08% | -5.71% | -18.47% | -2.00% | +4.74% | 2.71B |  |  | |
- Stock Market
- Equities
- 603707 Stock
- Charts Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
- Relative Strength Chart
